SDGR is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has some short-term technical strength, but the analyst trend is weakening, insiders are selling, and there is no strong proprietary buy signal. For an impatient investor, this is not a clear entry and I would not call it a good buy today.
SDGR closed at 16.94 after a 2.99% regular-session gain, which is constructive in the near term. MACD histogram is positive and expanding, showing improving momentum. RSI at 64.89 is moderately strong but not overbought. Moving averages are converging, which suggests the stock is still in a transition phase rather than a confirmed uptrend. Key levels: pivot 16.29, resistance 17.40 and 18.08, support 15.18 and 14.50. The price is sitting above pivot, so near-term trend is positive, but not strong enough to justify an aggressive long-term buy on technicals alone.

["Price closed higher on the session and is trading above the pivot level, indicating short-term momentum improvement.", "MACD is positive and expanding, which supports a constructive near-term trend.", "Options positioning is bullish, with low put-call ratios indicating call-side preference.", "Similar-pattern trend data suggests modest upside over the next week and month."]
["Morgan Stanley cut its price target to $17 from $19 and kept Equal Weight.", "KeyBanc also lowered its target to $20 from $25, showing declining analyst expectations.", "Insiders are selling, and the selling amount has increased sharply over the last month.", "Hedge funds are neutral, with no meaningful accumulation trend.", "No AI Stock Picker signal today and no recent SwingMax signal."]
No usable latest-quarter financial snapshot was provided for SDGR, so I cannot confirm current revenue or earnings growth trends from the supplied data. Because of that, there is no strong financial evidence here to support an aggressive long-term buy decision. The available data is insufficient to show a clearly accelerating fundamental story.
Analyst sentiment has turned more cautious. Morgan Stanley lowered its target to $17 and kept Equal Weight, while KeyBanc cut its target to $20 but remained Overweight. That means Wall Street is split: there is still some upside-oriented coverage, but the target cuts show fading enthusiasm. Overall, the pros view is mixed-to-neutral rather than strongly bullish.